Carl Zeiss Meditec looks back on successful financial year
11-Dec-2012
- Germany
The proportion of employees working in our Research and Development (R&D) department, on the innovations of the future, remains high at around 16 percent. In the reporting year Carl Zeiss Meditec invested 10.8 percent of its revenue in R&D.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.